000212534 001__ 212534
000212534 005__ 20240229154913.0
000212534 0247_ $$2doi$$a10.1007/s00761-022-01259-9
000212534 0247_ $$2ISSN$$a2731-7226
000212534 0247_ $$2ISSN$$a0947-8965
000212534 0247_ $$2ISSN$$a1433-0415
000212534 0247_ $$2ISSN$$a2731-7234
000212534 037__ $$aDKFZ-2023-00219
000212534 082__ $$a610
000212534 1001_ $$0P:(DE-HGF)0$$ade Villiers, Ethel-Michele$$b0$$eFirst author
000212534 245__ $$aSpecific infections as triggers of cancer and chronic neurological diseases.[Spezifische Infektionen als Auslöser von Krebs und chronischen neuronalen Erkrankungen].
000212534 260__ $$aNew York$$bSpringer Medizin$$c2023
000212534 3367_ $$2DRIVER$$aarticle
000212534 3367_ $$2DataCite$$aOutput Types/Journal article
000212534 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1686145162_31662
000212534 3367_ $$2BibTeX$$aARTICLE
000212534 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000212534 3367_ $$00$$2EndNote$$aJournal Article
000212534 500__ $$a#EA:F200#LA:F200# / 29, pages 247–259 (2023)
000212534 536__ $$0G:(DE-HGF)POF4-316$$a316 - Infektionen, Entzündung und Krebs (POF4-316)$$cPOF4-316$$fPOF IV$$x0
000212534 588__ $$aDataset connected to CrossRef, Journals: inrepo02.dkfz.de
000212534 7001_ $$0P:(DE-He78)3f43953e63fd34eca1891c5a0d9d344c$$azur Hausen, Harald$$b1$$eLast author$$udkfz
000212534 773__ $$0PERI:(DE-600)3120761-3$$a10.1007/s00761-022-01259-9$$p247–259$$tDie Onkologie$$v29$$x2731-7226$$y2023
000212534 909CO $$ooai:inrepo02.dkfz.de:212534$$pVDB
000212534 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000212534 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)3f43953e63fd34eca1891c5a0d9d344c$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000212534 9131_ $$0G:(DE-HGF)POF4-316$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vInfektionen, Entzündung und Krebs$$x0
000212534 9141_ $$y2023
000212534 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2022-11-29$$wger
000212534 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2022-11-29$$wger
000212534 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2022-11-29
000212534 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2022-11-29
000212534 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-27
000212534 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-27
000212534 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-27
000212534 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-27
000212534 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bONKOLOGIE-GER : 2022$$d2023-10-27
000212534 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2023-10-27
000212534 9202_ $$0I:(DE-He78)F200-20160331$$kF200$$lF200 AG Episomal-Persistierende DNA in Krebs- und chron. Erkrankungen$$x0
000212534 9201_ $$0I:(DE-He78)F200-20160331$$kF200$$lF200 AG Episomal-Persistierende DNA in Krebs- und chron. Erkrankungen$$x0
000212534 9200_ $$0I:(DE-He78)F200-20160331$$kF200$$lF200 AG Episomal-Persistierende DNA in Krebs- und chron. Erkrankungen$$x0
000212534 980__ $$ajournal
000212534 980__ $$aVDB
000212534 980__ $$aI:(DE-He78)F200-20160331
000212534 980__ $$aUNRESTRICTED